BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200818
DTEND;VALUE=DATE:20200819
DTSTAMP:20260515T122656
CREATED:20200630T114013Z
LAST-MODIFIED:20200630T114013Z
UID:26126-1597708800-1597795199@www.pharmajournalist.com
SUMMARY:Hemophilia Drug Development Summit – Running Digitally for 2020
DESCRIPTION:With the recent Hemlibra approval and the gene therapy revolution\, we are seeing a much-needed race to innovate more effective\, long-lasting and curative therapies for hemophilia and acquired bleeding disorders. \nAs such\, the 3rd Hemophilia Drug Development Summit is going digital and remains dedicated to bringing to patients more effective commercially and clinically translated therapies from small molecules to gene therapies to improve patients’ quality of life. \n \nBringing together over 100 of the world’s leading experts and drug developers\, we discuss how to develop new therapies for a responsive subset of hemophiliac patients\, optimize clinical trial development (setup and management) and discuss the patient/payer paradigm to ensure these novel therapies are affordable and accessible. \nBrought direct to your home office with a jam packed agenda and online virtual networking opportunities\, this exclusive virtual summit will delve into the challenges of treating each patient subset\, as well as hearing the latest advancements in gene therapy and discussing the critical hurdles that need to be overcome to meet the unmet clinical need of all patients. \nJoin us as we unite drug developers and researchers on a dedicated online platform and look to the innovation driving the field towards more long-acting and curative therapies to improve patient quality of life. \nTo know more about Hemophilia Drug Development Summit please click here.
URL:https://www.pharmajournalist.com/event/hemophilia-drug-development-summit-running-digitally-for-2020/
LOCATION:Virtual Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR